阳普医疗股票讨论区

Investors believe the company will underperform the broader industry, leading to a low P/S ratio. The company's shrinking revenue and the industry's projected growth are key factors. Shareholders accept the low P/S, conceding future revenue probably won't surprise. If recent trends continue, the share price may not move strongly in either direction.